Formation of monofunctional cisplatin-DNA adducts in carbonate buffer.
Carbonate in its various forms is an important component in blood and the cytosol. Since, under conditions that simulate therapy, carbonate reacts with cisplatin to form carbonato complexes, one of which is taken up and/or modified by the cell [C.R. Centerwall, J. Goodisman, D.J. Kerwood, J. Am. Chem. Soc., 127 (2005) 12768-12769], cisplatin-carbonato complexes may be important in the mechanism of action of cisplatin. In this report we study the binding of cisplatin to pBR322 DNA in two different buffers, using gel electrophoresis. In 23.8mM HEPES, N-(2-hydroxyethyl)-piperazine-N'-2-ethanesulfonic acid, 5mM NaCl, pH 7.4 buffer, cisplatin produces aquated species, which react with DNA to unwind supercoiled Form I DNA, increasing its mobility, and reducing the binding of ethidium to DNA. This behavior is consistent with the formation of the well-known intrastrand crosslink on DNA. In 23.8mM carbonate buffer, 5mM NaCl, pH 7.4, cisplatin forms carbonato species that produce DNA-adducts which do not significantly change supercoiling but enhance binding of ethidium to DNA. This behavior is consistent with the formation of a monofunctional cisplatin adduct on DNA. These results show that aquated cisplatin and carbonato complexes of cisplatin produce different types of lesions on DNA and they underscore the importance of carrying out binding studies with cisplatin and DNA using conditions that approximate those found in the cell.
Binter
Alexandra
A
Department of Chemistry, Syracuse University, 111 College Place, Rm 1-014 CST, Syracuse, NY 13244-4100, USA.
Goodisman
Jerry
J
Dabrowiak
James C
JC
D002021:Buffers; D002254:Carbonates / Q000737:chemistry*; D002945:Cisplatin / Q000138:chemical synthesis*; D018736:DNA Adducts / Q000138:chemical synthesis*; D006531:HEPES; D006863:Hydrogen-Ion Concentration
D002021:Buffers; D002254:Carbonates; D018736:DNA Adducts; C057270:cisplatin-DNA adduct; D002945:Cisplatin; D006531:HEPES